Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06377943
Other study ID # SIAT-IRB-240415-H0718
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date May 1, 2024
Est. completion date October 31, 2024

Study information

Verified date April 2024
Source Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences
Contact John R Speakman, PhD
Phone 15810868669
Email j.speakman@abdn.ac.uk
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This Study is focused on the interaction between resting metabolic rate (RMR), physical activity (PA), and thyroid hormones (TH). TH controls almost all the cell activities of the body so, it is known as one of the major regulatory hormones. This is the reason for individuals who suffer from thyroid disorders show abnormal metabolism. Recently it was suggested that interindividual variations in thyroid hormone levels also influence daily physical activity.


Description:

In this study, investigators will recruit adult females with a BMI ≥18.5. After the screening process, eligible volunteers will undergo certain measurements including body composition, resting metabolism daily physical activity, thyroid hormone levels, and total energy expenditure. The investigators will access the changes in resting metabolism and daily physical activities with the differences in thyroid hormone levels.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 50
Est. completion date October 31, 2024
Est. primary completion date July 31, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 50 Years
Eligibility Inclusion Criteria: - Female age =18; - BMI=18.5 Exclusion Criteria: - Intended weight change exceeding 2kg within the past three months; - Having any special medical diets or having eating disorders; - Pregnant women or breastfeeding women; - People who have metal implants in their bodies; - Patients with metabolic diseases, infectious diseases, and genetic disorders such as hypothyroidism, and hyperthyroidism; - Patients with a personal or family history of medullary thyroid carcinoma (MTC), or patients with rare type 2 multiple endocrine tumor syndrome (MEN2); People with a fear of needles (Trypanophobia), claustrophobia; People who are fear of blood (Hemophobia) or pathological hypotension;

Study Design


Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences

Outcome

Type Measure Description Time frame Safety issue
Primary Body weight Subjects will be asked to fast overnight and weight will be measured using a calibrated Seca body weight scale first thing in the morning on subjects wearing light clothes and no shoes. Measurements will take at the first day of the visit
Primary Height Measured by seca 217 stable stadiometer. Subjects wearing no shoes. Measurements will take at the first day of the visit
Primary Waist and Hip circumferences Waist and Hip circumferences will be measured using a whole body laser scanner. Measurements will take at the first day of the visit
Primary Fat mass Fat mass will be measured by Magnetic Resonance Imaging (Shanghai united imaging, uMR 790 ). Measurements will take at the first day of the visit
Primary Far free mass Fat free mass will be measured by Bioimpedance Analysis (Tanita, MC-980). Measurements will take at the first day of the visit
Primary Bone mass Bone mass will be measured by DEXA (Hologic). Measurements will take at the first day of the visit
Primary Resting Metabolism Resting energy expenditure will be measured using indirect calorimetry via a respiratory hood system (Cosmed). The subject attends the lab after an overnight fast. The person lies down on a flatbed and the hood is placed over their head. Metabolic rates (oxygen consumption and CO2 production) are monitored for 30 minutes. Calorimeters will be assessed with a turbine test to ensure the accuracy of measurements. Validation via an alcohol burn will be performed monthly. Measurements will take at the first day of the visit.
Primary Physical activity Physical activity of the participants will be recorded using GT3X accelerometer worn near the hip for a consecutive period of 7 days. The monitor should not be worn while bathing or swimming. The first day is discarded along with any day where the wear time is less than 12 hours. For a valid measure, the goal is to get 2 weekday and 2 weekend days. Measurements last for 14 days
Primary Thyroid hormone Nurses will collect the blood samples on day 1. Levels of circulating thyroid hormones will be measured using radio immune assay. Blood samples will collect at the first day of the visit.
Secondary Total energy expenditure Total energy expenditure (TEE) will be measured using the DLW method. Urine samples from all participants in the DLW subset will be stored at -20 oC and analyzed in the laboratory of Dr. John Speakman at the Shenzhen Institute of Advanced Technology, Chinese Academy of sciences. Isotopes will be measured in a benchtop near-infrared isotope gas analyzer, and mean CO2 production will be calculated from isotope ratios using the recently derived equation (Speakman et al 2021: Cell reports medicine). TEE will then be calculated using mean CO2 production using the Weir equation. Measurements take for 14 days
See also
  Status Clinical Trial Phase
Enrolling by invitation NCT04085913 - Exparel Injection Effect on Postoperative Opioid Usage Early Phase 1
Completed NCT04647006 - Comparison of TOETVA and Conventional Thyroidectomy N/A
Completed NCT04763122 - Thyroid Cancer in United Arab Emirates
Completed NCT05323539 - Comparison of Thyroid Volumes in Patients With and Without Endometrioma N/A
Recruiting NCT04160637 - Is There Benefit From Early Postoperative PTH Monitoring?
Completed NCT03597659 - PheWAS of a Polygenic Predictor of Thyroid Function
Completed NCT03430141 - A Nutritarian Study to Evaluate the Effectiveness of Lifestyle Changes in Chronic Disease Prevention, Especially Cancer N/A
Recruiting NCT04115514 - Treatment of ARDS With Instilled T3 Phase 2
Recruiting NCT04623801 - Laser Ablation of Papillary Thyroid Microcarcinoma Phase 2
Recruiting NCT03754621 - Upper Limit for TSH of First and Second Trimester Pregnancy in Turkey
Withdrawn NCT03060499 - Post Thyroidectomy Myocardial Function
Completed NCT05276271 - The Effect of Levetiracetam on Lipid Profile in Children
Recruiting NCT04014660 - Prevention av Autoimmunitet Med Laktobaciller N/A
Completed NCT02304172 - The Efficacy and Safety of Thunderbeat in Thyroid Surgery N/A
Recruiting NCT04571736 - Pilot Study for Thyroid Surgery by Preoperative Video Support and Personalized and Secure Web Platform N/A
Recruiting NCT05510609 - Three-dimensional Ultrasonography Thyroid Volume Measurement. N/A
Active, not recruiting NCT05328076 - Parathyroid Vascularization During Total Thyroidectomy Using Indocyanine Green Angiography
Recruiting NCT03933358 - Effect of Thyroid Hormone on Post-Myocardial Infarction Remodeling and Prognosis in STEMI Patients
Active, not recruiting NCT02681328 - Randomized Trial Comparing Performance of Molecular Markers for Indeterminate Thyroid Nodules
Completed NCT03816371 - The Effects of Different Degrees of Head-of-bed Elevation N/A